|
I have just been told the good news. It will be interesting to see what the qualification requirements are.
Well done and a big thank you to those MDS patients in Australia who campaigned hard to get this approved. I am sure that you played a part in this.
Honey
__________________
Dx June 2013 MDS del 5q and 7t. Further chromosone changes August 2017. Lenolidomide and 10 months on Azacytadine failed. Transition to AML August 2018 failed induction chemo. Trial drug FT2101 failed at 6 months. Next on Venetoclax with cytoterabine.
|